MAPT and Alzheimer disease: Increased levels of plasma NfL have been observed in mouse models of PD A53T- alpha-synuclein, tauopathy P301S-Tau and AD APP/PS1 (amyloid precursor protein/presenilin 1) (Bacioglu et al., 2016).